2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia

Page, Richard L.; Joglar, José A.; Caldwell, Mary A.; Calkins, Hugh; Conti, Jamie B.; Deal, Barbara J.; Estes, N.A. Mark; Field, Michael E.; Goldberger, Zachary D.; Hammill, Stephen C.; Indik, Julia H.; Lindsay, Bruce D.; Olshansky, Brian; Russo, Andrea M.; Shen, Win Kuang; Tracy, Cynthia M.; Al‐Khatib, Sana M.

doi:10.1161/cir.0000000000000311

Cited by 337 publications

(157 citation statements)

References 604 publications

(240 reference statements)

Supporting

Mentioning

140

Contrasting

Unclassified

Order By: Relevance

“…PSVTs are managed using a variety of approaches depending on the underlying mechanism and the clinical stability and frequency of episodes 1. PSVTs can have a negative effect on patient quality of life by causing symptoms during episodes (eg, palpitations, chest pain, dizziness, syncope, and shortness of breath), by imposing restrictions on patient activities, and by leading to medication‐related side effects.…”

Section: Introductionmentioning

confidence: 99%

Contemporary Burden and Correlates of Symptomatic Paroxysmal Supraventricular Tachycardia

Hlatky

Liu

et al. 2018

JAHA

View full text Add to dashboard Cite

BackgroundContemporary data about symptomatic paroxysmal supraventricular tachycardia (PSVT) epidemiology are limited. We characterized prevalence and correlates of symptomatic PSVT within a large healthcare delivery system and estimated national PSVT burden.Methods and ResultsWe identified adults with an encounter for potential PSVT between 2010 and 2015 in Kaiser Permanente Northern California, excluding those with prior known atrial fibrillation or atrial flutter. We adjudicated medical records, ECGs, and other monitoring data to estimate positive predictive values for targeted International Classification of Diseases (ICD), 9th and 10th Revisions codes in inpatient, emergency department, and outpatient settings. Combinations of diagnosis codes and settings were used to calculate PSVT prevalence, and PSVT correlates were identified using multivariable regression. We estimated national rates by applying prevalence estimates in Kaiser Permanente to 2010 US Census data. The highest positive predictive values included codes for “PSVT” in the emergency department (82%), “unspecified cardiac dysrhythmia” in the emergency department (27%), “anomalous atrioventricular excitation” as a primary inpatient diagnosis (33%), and “unspecified paroxysmal tachycardia” as a primary inpatient diagnosis (23%). Prevalence of symptomatic PSVT was 140 per 100 000 (95% confidence interval, 100–179) and was higher for individuals who were older, women, white or black, or who had valvular heart disease, heart failure, diabetes mellitus, lung disease, or prior bleeding. We estimate the national prevalence of symptomatic PSVT to be 168 per 100 000 (95% confidence interval, 120–215).ConclusionsSelected diagnostic codes in inpatient and emergency department settings may be useful to identify symptomatic PSVT episodes. We project that at least 0.168% of US adults experience symptomatic PSVT, and certain characteristics can identify people at higher risk.

show abstract

Section: Introductionmentioning

confidence: 99%

Contemporary Burden and Correlates of Symptomatic Paroxysmal Supraventricular Tachycardia

Hlatky

Liu

et al. 2018

JAHA

View full text Add to dashboard Cite

show abstract

“…Dual AV node physiology is a frequent finding, being described in up to 90% of patients in a small case sample of heavily sedated patients undergoing electrophysiological study (EPS) [2], but does not always imply an AVNRT. Radiofrequency transcatheter ablation (RFCA) of the slow pathway is at present considered the first choice treatment for AVNRT because of its high acute and long-term efficacy [3]. Although RFCA is widely used, it is still associated with a risk of irreversible complete AV block (up to 1-2%) [4].…”

Section: Introductionmentioning

confidence: 99%

Cooling dynamics: a new predictor of long-term efficacy of atrioventricular nodal reentrant tachycardia cryoablation

Matta

Anselmino

Scaglione

et al. 2016

J Interv Card Electrophysiol

View full text Add to dashboard Cite

Purpose. Catheter ablation of the slow pathway is the most effective treatment for atrioventricular nodal reentrant tachycardia (AVNRT). Cryoenergy, compared to radiofrequency, relates to lower heart block risk, but higher incidence of AVNRT recurrences. The aim of this study is to confirm safety and efficacy of AVNRT cryoablation and to identify predictors of long-term recurrences. Conclusions. AVNRT cryoablation is safe and effective. Long-term recurrence rate was 11.7%. An ablation approach directed to the complete elimination of dual AV node physiology, along with assessment of tissue's cooling dynamics, hold the potential to improve long-term AVNRT cryoablation efficacy. Methods andAbstract word count: 244 2

show abstract

“…[1] It is defined as a regular atrial rhythm that arise outside of the sinus node, from a single site within the left or right atrium, which may be due either by a micro reentry or by the exaltation of the automatism of an ectopic focus and may also result from triggered activity. [2] Although AV conduction is usually 1:1 and the PR interval is often in the normal range producing a long R-P interval, occasionally, especially when the heart rate is particularly high or the AV conduction is markedly increased, [3] a focal AT with a 1:1 AV conduction may have a short RP interval (< 90 ms).…”

Section: Discussionmentioning

confidence: 99%

“…[2] Although AV conduction is usually 1:1 and the PR interval is often in the normal range producing a long R-P interval, occasionally, especially when the heart rate is particularly high or the AV conduction is markedly increased, [3] a focal AT with a 1:1 AV conduction may have a short RP interval (< 90 ms). In these cases it is necessary to differentiate AT from other SVTs and in particular from the typical AVNRT, that is one of the most common paroxysmal SVTs [1] and that is a regular SVT. Normally it initiate with a premature atrial beat or more rarely with a ventricular premature beat, and it has a "short RP" interval because the atrial activation coincide with ventricular activation or follow it with a short time and thus, on electrocardiographic trace, P wave is placed nearer the previous QRS complex than the following one.…”

Section: Discussionmentioning

confidence: 99%

An unusual focal atrial tachycardia that simulates a common node reentrant tachycardia: A case report

Maida

Cirrincione

Daidone

et al. 2017

CRIM

View full text Add to dashboard Cite

Focal atrial tachycardia is a relatively uncommon paroxysmal supraventricular tachycardia. Although atrioventricular conduction is regularly 1:1 and the PR interval is often in the normal range, occasionally a 1:1 atrial tachycardia may have a short RP interval, especially when the heart rate is particularly high or the atrioventricular conduction is markedly increased. In these cases, it is necessary to differentiate focal atrial tachycardia from common atrioventricular nodal reentrant tachycardia , which is the most frequent form of paroxysmal supraventricular tachycardia. We describe a case of unusual focal atrial tachycardia with a short RP interval (< 90 ms) in a patient with a marked AV first-degree block which simulates a typical atrioventricular nodal reentrant tachycardia.

show abstract

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia

Cited by 337 publications

References 604 publications

Contemporary Burden and Correlates of Symptomatic Paroxysmal Supraventricular Tachycardia

Contemporary Burden and Correlates of Symptomatic Paroxysmal Supraventricular Tachycardia

Cooling dynamics: a new predictor of long-term efficacy of atrioventricular nodal reentrant tachycardia cryoablation

An unusual focal atrial tachycardia that simulates a common node reentrant tachycardia: A case report

Contact Info

Product

Resources

About